Abstract
To determine whether immunocomplexes (ICs) containing advanced glycation end product (AGE)-LDL (AGE-LDL) and oxidized LDL (oxLDL) contribute to the development of retinopathy over a 16-year period in subjects with type 1 diabetes.
| Original language | English |
|---|---|
| Pages (from-to) | 1333-40 |
| Number of pages | 8 |
| Journal | Diabetes Care |
| Volume | 35 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Jun 2012 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adult
- Albuminuria
- Biological Markers
- Cholesterol, LDL
- Diabetes Mellitus, Type 1
- Diabetic Retinopathy
- Disease Progression
- Female
- Glycosylation End Products, Advanced
- Hemoglobin A, Glycosylated
- Humans
- Lipoproteins, LDL
- Male
- Proportional Hazards Models
- Risk Factors
Fingerprint
Dive into the research topics of 'High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver